Collins C - Search Results

1

Modeling drug mechanism knowledge using evidence and truth maintenance.

Boyce RD, Collins C, Horn J, Kalet I. Boyce RD, et al. Among authors: collins c. IEEE Trans Inf Technol Biomed. 2007 Jul;11(4):386-97. doi: 10.1109/titb.2007.890842. IEEE Trans Inf Technol Biomed. 2007. PMID: 17674621

2

Qualitative pharmacokinetic modeling of drugs.

Boyce R, Collins C, Horn J, Kalet IJ. Boyce R, et al. Among authors: collins c. AMIA Annu Symp Proc. 2005;2005:71-5. AMIA Annu Symp Proc. 2005. PMID: 16779004 Free PMC article.

3

Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment.

Boyce R, Collins C, Horn J, Kalet I. Boyce R, et al. Among authors: collins c. J Biomed Inform. 2009 Dec;42(6):979-89. doi: 10.1016/j.jbi.2009.05.001. Epub 2009 May 10. J Biomed Inform. 2009. PMID: 19435613 Free PMC article.

4

Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions.

Boyce R, Collins C, Horn J, Kalet I. Boyce R, et al. Among authors: collins c. J Biomed Inform. 2009 Dec;42(6):990-1003. doi: 10.1016/j.jbi.2009.05.010. Epub 2009 Jun 16. J Biomed Inform. 2009. PMID: 19539050 Free PMC article.

5

Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software.

Boyce RD, Collins C, Clayton M, Kloke J, Horn JR. Boyce RD, et al. Among authors: collins c. Ann Pharmacother. 2012 Oct;46(10):1287-98. doi: 10.1345/aph.1R150. Epub 2012 Oct 2. Ann Pharmacother. 2012. PMID: 23032655

6

Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.

Grizzle AJ, Horn J, Collins C, Schneider J, Malone DC, Stottlemyer B, Boyce RD. Grizzle AJ, et al. Among authors: collins c. J Med Internet Res. 2019 Jan 4;21(1):e11182. doi: 10.2196/11182. J Med Internet Res. 2019. PMID: 30609981 Free PMC article.

7

Risk and predictability of drug interactions in the elderly.

Levy RH, Collins C. Levy RH, et al. Among authors: collins c. Int Rev Neurobiol. 2007;81:235-51. doi: 10.1016/S0074-7742(06)81015-9. Int Rev Neurobiol. 2007. PMID: 17433928 Review.

8

Designing mobile support for glycemic control in patients with diabetes.

Harris LT, Tufano J, Le T, Rees C, Lewis GA, Evert AB, Flowers J, Collins C, Hoath J, Hirsch IB, Goldberg HI, Ralston JD. Harris LT, et al. Among authors: collins c. J Biomed Inform. 2010 Oct;43(5 Suppl):S37-S40. doi: 10.1016/j.jbi.2010.05.004. J Biomed Inform. 2010. PMID: 20937484 Free article.

9

Prediction of maximum exposure in poor metabolizers following inhibition of nonpolymorphic pathways.

Collins C, Levy R, Ragueneau-Majlessi I, Hachad H. Collins C, et al. Curr Drug Metab. 2006 Apr;7(3):295-9. doi: 10.2174/138920006776359301. Curr Drug Metab. 2006. PMID: 16611023

10

Exploring the Design and Role of Mobile Apps for Healthcare Providers to Find Teratogenic Information.

Lie L, Shetty V, Gupta K, Polifka JE, Markham G, Albee S, Collins C, Hsieh G. Lie L, et al. Among authors: collins c. AMIA Annu Symp Proc. 2018 Apr 16;2017:1100-1109. eCollection 2017. AMIA Annu Symp Proc. 2018. PMID: 29854178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,961 results

Search Page

Filters